BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19351758)

  • 1. Increased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas.
    Lahat G; Lazar A; Wang X; Wang WL; Zhu QS; Hunt KK; Pollock RE; Lev D
    Clin Cancer Res; 2009 Apr; 15(8):2637-46. PubMed ID: 19351758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
    Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
    World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
    Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor-D is a key molecule that enhances lymphatic metastasis of soft tissue sarcomas.
    Yanagawa T; Shinozaki T; Watanabe H; Saito K; Raz A; Takagishi K
    Exp Cell Res; 2012 Apr; 318(7):800-8. PubMed ID: 22326461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
    Peng F; Zhong Y; Liu Y; Zhang Y; Xie Y; Lu Y; Zhang X; Li D
    Int J Oncol; 2017 Dec; 51(6):1920-1928. PubMed ID: 29075785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
    Wang XL; Fang JP; Tang RY; Chen XM
    BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
    Eroğlu A; Ersöz C; Karasoy D; Sak S
    Adv Clin Exp Med; 2017; 26(2):245-249. PubMed ID: 28791841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
    Špirić Z; Eri Ž; Erić M
    Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
    Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G
    Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.
    Choi WW; Lewis MM; Lawson D; Yin-Goen Q; Birdsong GG; Cotsonis GA; Cohen C; Young AN
    Mod Pathol; 2005 Jan; 18(1):143-52. PubMed ID: 15297858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Akt expression correlates with the VEGF-A and -C expression as well as the microvessel and lymphatic vessel density in breast cancer.
    Tsutsui S; Matsuyama A; Yamamoto M; Takeuchi H; Oshiro Y; Ishida T; Maehara Y
    Oncol Rep; 2010 Mar; 23(3):621-30. PubMed ID: 20126999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas?
    Kandemir NO; Barut F; Bektas S; Ozdamar SO
    Pathol Oncol Res; 2012 Apr; 18(2):253-62. PubMed ID: 21785902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis.
    Koyama Y; Kaneko K; Akazawa K; Kanbayashi C; Kanda T; Hatakeyama K
    Clin Breast Cancer; 2003 Dec; 4(5):354-60. PubMed ID: 14715111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
    Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
    Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
    Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
    BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic Vessel Density and Vascular Endothelial Growth Factor Expression in Squamous Cell Carcinomas of Lip and Oral Cavity: A Clinicopathological Analysis with Immunohistochemistry Using Antibodies to D2-40, VEGF-C and VEGF-D.
    Watanabe S; Kato M; Kotani I; Ryoke K; Hayashi K
    Yonago Acta Med; 2013 Mar; 56(1):29-37. PubMed ID: 24031149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on relationship between expression of podoplanin and lymph node metastasis in oral squamous cell carcinoma].
    Ren WH; Gao L; Xu Y; Zhao L; Zhi KQ; Qi H; Li P
    Shanghai Kou Qiang Yi Xue; 2012 Aug; 21(4):437-41. PubMed ID: 23135121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic vessel density and expressions of lymphangiogenic growth factors in salivary carcinomas.
    Mello MF; Costa AF; Freitas LL; Soares AB; Araujo VC; Tincani AJ; Martins AS; Altemani A
    Neoplasma; 2011; 58(4):331-6. PubMed ID: 21520990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.